The members of the American Association for Cancer Research (AACR) have elected Antoni Ribas, MD, PhD, as their President-Elect for 2019–2020. He will officially become President-Elect at the AACR Annual Meeting 2019, being held in Atlanta, March 29–April 3, and he will assume the presidency in April 2020 at the AACR Annual Meeting in San Diego.
The voting members of the AACR have also elected five members to serve on the AACR Board of Directors for the 2019–2022 term. These new directors, who are esteemed cancer researchers, will begin their terms at the AACR Annual Meeting 2019.
Ribas is professor of Medicine at the David Geffen School of Medicine at the University of California Los Angeles (UCLA); director of the UCLA Jonsson Comprehensive Cancer Center Tumor Immunology Program; and director of the Parker Institute for Cancer Immunotherapy Center at UCLA. He is an internationally recognized physician-scientist whose translational and clinical research focuses on developing new therapeutic options for patients with malignant melanoma.
As AACR President-Elect, Ribas will work with the Board of Directors and the AACR membership, which includes more than 42,000 members in 120 countries, to further the association’s mission to prevent and cure all cancers through research, education, communication, collaboration, funding for cancer research, and advocacy.
